EMAIL THIS PAGE TO A FRIEND

Molecular Cancer Therapeutics

Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.


PMID 25504633

Abstract

We're sorry this abstract is currently not available.